Colon tumors that lack CDX2 expression are more prone to have aggressive characteristics such as advanced stage, poor differentiation, vascularization, BRAF gene mutation, and the CpG island methylator profile (Dawson et al., 2014). The gene discussed is BRAF; the disease is colonic neoplasm.